CLINICAL_TRIALS
trial_result
· 2020-04-30
Clinical Trial Update: A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants [Phase 1]
Summary
Phase 1 clinical trial assessing LY900014 formulation at different injection sites in healthy participants.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2020-04-30